Pak seeks bigger SAARC to counter India's influence

October 12, 2016

Islamabad, Oct 12: Pakistan is exploring the possibility of creating a greater South Asian economic alliance to include China, Iran and neighbouring Central Asian republics as part of its bid counter India's influence in SAARC, a media report said today.pak

Dawn News, citing diplomatic observers, said Pakistan is exploring the possibility of creating a greater South Asian economic alliance to counter India's "controlling hold" on the eight-member South Asian Association for Regional Cooperation (SAARC).

A parliamentary delegation from Pakistan, which is now in New York, pitched this idea during its five-day visit to Washington last week, the report said.

"A greater South Asia is already emerging," Senator Mushahid Hussain Syed was quoted as saying in one of his interactions with the media.

"This greater South Asia includes China, Iran and the neighbouring Central Asian republics," he said.

He described the China-Pakistan Economic Corridor as the key economic route linking South Asia with Central Asia.

The Gwadar port, Syed said, would be the nearest warm water port, not only for China but also for the land-locked Central Asian states. "We want India to join this arrangement as well," said Syed.

Indians are "unlikely to accept" the offer as they are comfortable with the advantage that SAARC provides them, the report said.

"India used its influence in SAARC to isolate Pakistan when it announced that it would not attend the regional group's 19th summit, scheduled in Islamabad," the report said.

Citing continuous cross border terrorism by Pakistan, India had announced last month that "in the prevailing circumstances, the Indian government is unable to participate in the proposed Summit in Islamabad."

Besides India, four other SAARC members -- Bangladesh, Bhutan, Sri Lanka and Afghanistan -- had also pulled out of the summit.

"Among the eight SAARC nations, Afghanistan and Bangladesh are India's strong allies while Bhutan, surrounded by India from all sides, is too small to resist any move from New Delhi. The Maldives, Nepal and Sri Lanka have good ties with Pakistan, but they are not large enough to take on India," the report said.

The report cited that a senior diplomat had confirmed reports that Pakistan is actively seeking a new regional arrangement.

"Apparently, the showdown forced Pakistan to conclude that in its present shape, SAARC will always be dominated by India. That's why they are now talking about a greater South Asia," the diplomat was quoted as saying.

"Pakistan hopes that this new arrangement will give it more room to manoeuvre when India tries to force a decision on it," another diplomat said.

The report quoted diplomatic observers in Washington as saying that the proposed arrangement also suits China as it is also worried about India's rapidly growing influence in the region.

"They argue that China can play an important role in persuading Central Asian republics and Iran to join the new arrangement. But the observers warn that SAARC members will have little interest in supporting the idea," the report said.

"There is not much benefit for Bangladesh, Nepal and Sri Lanka in joining a land route far from their borders and Bangladesh and Sri Lanka have their own ports," it said.

The report stated thatt he member that is likely to get the most benefits from a greater South Asian alliance is Afghanistan, which is technically a land-locked Central Asian nation.

Any trade route that links South and Central Asian regions is good for Afghanistan, it noted.

"But observers believe that Afghanistan is too closely linked to India to join any arrangement that hurts India's interests. Afghanistan's presence in SAARC, however, justifies Pakistan's argument that Central Asian nations can be included in a greater South Asia.

Afghanistan applied for SAARC membership in 2006 and joined a year later, generating an interesting debate on the definition of South Asian identity because Afghanistan is a Central Asian country, the report said.

"But, as a South Asian diplomat pointed out, even if a greater South Asia became reality, there's no guarantee that its members would support Pakistan in its disputes with India," it said.

"Many Central Asian states have strong ties with India and Iran too has problems with Pakistan," the diplomat was quoted as saying.

Comments

Rikaz
 - 
Wednesday, 12 Oct 2016

India should not have cancelled this conference....

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 10,2020

Melbourne, Apr 10: Scientists have identified six drug candidates from more than 10,000 compounds that may help treat COVID-19.

The research, published in the journal Nature, tested the efficacy of approved drugs, drug candidates in clinical trials and other compounds.

"Currently there are no targeted therapeutics or effective treatment options for COVID-19," said Professor Luke Guddat from the University of Queensland in Australia.

"In order to rapidly discover lead compounds for clinical use, we initiated a programme of high-throughput drug screening, both in laboratories and also using the latest computer software to predict how different drugs bind to the virus," Guddat said.

The project targeted the main COVID-19 virus enzyme, known as the main protease or Mpro, which plays a pivotal role in mediating viral replication, the researchers said.

This makes it an attractive drug target for this virus, and as people don't naturally have this enzyme, compounds that target it are likely to have low toxicity, they said.

"We add the drugs directly to the enzyme or to cell cultures growing the virus and assess how much of each compound is required to stop the enzyme from working or to kill the virus. If the amount is small, then we have a promising compound for further studies," said Guddat.

After assaying thousands of drugs, researchers found of the six that appear to be effective in inhibiting the enzyme, one is of particular interest.

"We're particularly looking at several leads that have been subjected to clinical trials including for the prevention and treatment of various disorders such as cardiovascular diseases, arthritis, stroke, atherosclerosis and cancer," Guddat said.

Researchers said compounds that are already along the pipeline to drug discovery are preferred, as they can be further tested as antivirals at an accelerated rate compared to new drug leads that would have to go through this process from scratch.

"With continued and up-scaled efforts we are optimistic that new candidates can enter the COVID-19 drug discovery pipeline in the near future," Guddat said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

London, Mar 4: The UK government has reiterated its concern over the potential impact of the Citizenship Amendment Act (CAA) and said it is continuing to follow the events in India closely.

In response to an urgent question on “Recent Violence in India” tabled by Pakistani-origin Opposition Labour Party MP Khalid Mahmood in the House of Commons on Tuesday, UK’s Minister of State in the Foreign and Commonwealth Office (FCO) Nigel Adams said the UK engages with India at all levels, including on human rights, and also referred to the country's "proud history" of inclusive government and religious tolerance.

"The UK government also have concerns about the potential impact of the legislation (CAA),” said Adams, the Minister for Asia who was standing in for UK Foreign Secretary Dominic Raab, who is on a visit to Turkey.

"It is because of our close relationship with the government of India that we are able to discuss difficult issues with them and make clear our concerns where we have them, including on the rights of minorities. We will continue to follow events closely and to raise our concerns when we have with them,” said the minister.

While Mahmood, who had tabled the urgent question for an FCO statement, described the government response as “facile”, another Pakistani-origin MP Nusrat Ghani called on the government to relay the UK Parliament's concerns to the Indian authorities.

British Sikh Labour MP Tanmanjeet Singh Dhesi said the violence had brought back “painful personal memories” from the 1984 Sikh riots while he was studying in India and fellow Sikh MP Preet Kaur Gill also referenced 1984 in her intervention.

Other MPs sought to highlight the steps taken by the Indian authorities to restore “peace and tranquillity” in Delhi.

“He will be aware that it is not just Muslims who have been killed; Hindus have also been killed as part of the riots,” said Conservative Party MP Bob Blackman.

Scottish National Party (SNP) MP Alyn Smith sought the UK government’s intervention to share best practice around countering the online disinformation campaign being used in India to “inflame tensions”.

“We are in constant contact on these issues, and we know how important this is to Members of Parliament and their constituents, who may have family in the area,” said Adams, in his response.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
July 29,2020

If everything goes as Russia’s expectation, it will be world’s first country to approve a coronavirus vaccine for widespread in the second week of August despite safety and efficacy concerns, according to a report. The adenoviral vector-based vaccine developed by Russian military and government researchers is currently in phase 2 trials.

According to a report from CNN, Russian officials are hoping to get approval for the COVID-19 vaccine developed by the Moscow-based Gamaleya Institute on Agust 10 or even before that. The officials told the outlet that the vaccine will be approved for public use with frontline healthcare workers receiving it first.

“It’s a Sputnik moment,” said Kirill Dmitriev, head of Russia’s sovereign wealth fund, which is financing Russian vaccine research, referring to the successful 1957 launch of the world’s first satellite by the Soviet Union, according to CNN.

“Americans were surprised when they heard Sputnik’s beeping. It’s the same with this vaccine. Russia will have got there first,” he was quoted as saying.

However, Russia is yet to release the scientific data on its coronavirus vaccine trials, hence, questions remain about the safety and efficacy of the vaccine, said the report. The vaccine is in the second phase of testing with developers planning to launch the phase 3 trials sometime after August 3.

Earlier, Interfax reported, citing Health Minister Mikhail Murashko, that the vaccine will be widely used in parallel with phase 3 trials. He said the country plans to vaccinate medics who are at high-risk for COVID-19 next month before clinical trials are completed.

Murashko added that individuals at higher risk of getting infected with the coronavirus such as older people or those with health conditions will also be prioritised for the vaccine, although he did not estimate or reveal when that would happen. The minister added 800 people will be recruited for the phase 3 trials.

Meanwhile, health officials were more cautious considering the fact that human testing of the vaccine is incomplete, and the state registration is expected to begin after August 3, reported The Moscow Times.

On Monday, Moderna and Pfizer announced the commencement of the final phase 3 trials of their candidate vaccines against the SARS-CoV-2 virus, which has so far claimed at least 654,477 lives and infected 16,514,500 people worldwide. 

Researchers will recruit up to 30,000 volunteers in separate trials both backed by the US government. India's first indigenous coronavirus vaccine, COVAXIN, is undergoing phase 1 human clinical trials across the country. More than 150 COVID-19 vaccines are being developed all over the world with at least six candidates already in late-stage clinical trials.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.